描述
Perjeta Pertuzumab 420mg 注射液由印度罗氏制药有限公司生产,每支注射液含有 420 毫克帕妥珠单抗。每瓶的剂量可能有所不同,因此 Perjeta Pertuzumab 420mg 注射液是其他疾病的有效治疗选择。购买帕妥珠单抗药物无需医生处方。Indogenmed 经销各种类型的帕妥珠单抗仿制药。
Rx (Prescription Medicine)
USD $ 8,607.00
Perjeta Pertuzumab 420mg 注射液由印度罗氏制药有限公司生产,每支注射液含有 420 毫克帕妥珠单抗。每瓶的剂量可能有所不同,因此 Perjeta Pertuzumab 420mg 注射液是其他疾病的有效治疗选择。购买帕妥珠单抗药物无需医生处方。Indogenmed 经销各种类型的帕妥珠单抗仿制药。
| Brand Name | |
|---|---|
| Pack Quantity | 1 Injection, 3 Injections, 5 Injections, 1 Vial |
| Country Of Origin | Switzerland |
| Medicine Form | Vial |
| Medicine Type | Generic |
| Molecule | |
| Packaging Type | Vial |
| Rx Status | Rx (Prescription Medicine) |
| Strength | 420 mg |
只有已购买此产品的登录客户才能发表评价。
未库存此 exact 强度的其他品牌,因此这些是其他强度的 Pertuzumab. 未经开方医生建议,请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
帕妥珠单抗 420 毫克注射液 有 1 个评价
目前还没有评价